Back to search

Japan· JP-6112401A1011

クリンダマイシンリン酸エステル

A clindamycin product containing クリンダマイシンリン酸エステル, registered in Japan, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

On Japan’s NHI price listATC J01FF01

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedクリンダマイシンリン酸エステルATCJ01FF01REGISTER NO.JP-6112401A1011PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Clindamycin is registered in 15 of 19 countries.

Countries holding a registration under ATC J01FF01 (clindamycin), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 8 of them publish a price we can compare per daily dose

Clindamycin · ATC J01FF01

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of clindamycin costs, country by country.

Normalised to the WHO defined daily dose (1.2 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Clindamycin · price per daily dose (1.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$9.84
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
クリンダマイシンリン酸エステル
Manufacturer
—
Country
Japan (JP)
ATC code
J01FF01
ATC class
Clindamycin
Defined daily dose
1.2 g, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

378 interactions on record for clindamycin.

Graded by severity as the source publishes them — 72 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Clindamycin · interactions on record

378 records

  • 72 moderate
  • 2 minor
  • 304 info

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • KaolinA07BC02moderate
  • AttapulgiteA07BC04moderate
  • BalsalazideA07EC04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/07a2a59b-fcd4-40d6-a608-f53c55e7ea9e
GET /v1/drugs/07a2a59b-fcd4-40d6-a608-f53c55e7ea9e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "300mg1管",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "6112401A1011",
  "category": "注射薬",
  "price_yen": null,
  "generic_name": "クリンダマイシンリン酸エステル",
  "product_name_jp": null,
  "therapeutic_class": "6112",
  "transitional_expiry": "R9.3.31まで"
}

See everything about clindamycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.